• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国皮肤恶性黑色素瘤的流行病学变化及特定年龄发病率:1981 - 2018年按年龄、性别和解剖部位对国家癌症登记数据的分析

Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: An analysis of the national cancer registration data by age, gender and anatomical site, 1981-2018.

作者信息

Memon Anjum, Bannister Peter, Rogers Imogen, Sundin Josefin, Al-Ayadhy Bushra, James Peter W, McNally Richard J Q

机构信息

Department of Primary Care and Public Health, Brighton and Sussex Medical School, UK.

Department of Pathology, Faculty of Medicine, Kuwait University, Kuwait.

出版信息

Lancet Reg Health Eur. 2021 Jan 6;2:100024. doi: 10.1016/j.lanepe.2021.100024. eCollection 2021 Mar.

DOI:10.1016/j.lanepe.2021.100024
PMID:34557790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8454583/
Abstract

BACKGROUND

The incidence of cutaneous malignant melanoma, which is mostly attributable (86%) to UV radiation exposure, has been steadily increasing over the past four decades in predominantly fair-skinned populations. Although public health campaigns are increasing sun-protective behaviour in England, their effect on melanoma incidence is largely unknown. We conducted a retrospective population-based cohort study to examine whether there have been changes in the epidemiology of melanoma in England during the past four decades.

METHODS

Individual level data for patients diagnosed with melanoma in England during 1981-2018 were obtained from the Office for National Statistics/Public Health England. Average annual incidence rates were calculated by three age categories (0-34, 35-64, 65+ years), gender and anatomical site during the seven five-year time periods (1981-85 to 2011-15) and the recent three-year period (2016-18). The percentage change in incidence was calculated as change in the average incidence rate from the first (1981-85) to the last time period (2016-18). The Average Annual Percentage Change (AAPC) was estimated using the slope of the linear trend line fitted to the incidence rates by year of diagnosis.

FINDINGS

During the 38-year period (1981-2018), a total of 265,302 cases of melanoma (45.7% males, 54.3% females) were registered in England. The average annual number of cases increased from 837/year in 1981-85 to 6963/year in 2016-18 in males (+732%), and from 1609/year in 1981-85 to 6952/year in 2016-18 in females (+332%). In the young age-group (0-34 years), the average annual incidence rates initially increased from 1981-85 to 2001-05 and then stabilised during the recent period (2006-18). In the middle age group (35-64 years), the rates increased by +332% (AAPC, 10.4%) in males (from 5.6/100,000 in 1981-85 to 24.2/100,000 in 2016-18) and +185% (AAPC, 5.7%) in females (from 10.2/100,000 in 1981-85 to 29.1/100,000 in 2016-18); and in the old age-group (65+ years) the rates increased by +842% (AAPC, 25.7%) in males (from 9.6/100,000 in 1981-85 to 90.4/100,000 in 2016-18) and +381% (AAPC, 11.2%) in females (from 12.5/100,000 in 1981-85 to 60.1/100,000 in 2016-18). The largest increase in incidence in both males and females was observed for melanoma of the trunk (+817%, AAPC, 24.8% in males and +613%, AAPC, 18.3% in females), followed by melanoma of upper limb (+750%, AAPC, 22.9% in males and 518%, AAPC, 15.5% in females).

INTERPRETATION

It appears that the incidence of melanoma among young people in England has stabilised (or levelled off) in recent decades, whereas it continues to increase substantially in older population. These findings suggest that public health campaigns targeted at children/adolescents/parents may be favourably influencing melanoma incidence. The steeper increase in incidence in males is consistent with their relatively greater sun exposure and poor sun-protective behaviour. All the available evidence suggests that the enormous increase in the melanoma of the trunk and upper limb, since the 1980s, is most likely due to increasing trend in intermittent high intensity recreational UV radiation exposure (e.g. sunbathing, holidaying in places with strong sunlight, indoor tanning).

FUNDING

This work was supported by Brighton and Sussex Medical School (BSMS).

摘要

背景

皮肤恶性黑色素瘤的发病率在过去四十年中在主要为白皮肤的人群中稳步上升,其中大部分(86%)归因于紫外线辐射暴露。尽管英国的公共卫生运动正在增加防晒行为,但其对黑色素瘤发病率的影响在很大程度上尚不清楚。我们进行了一项基于人群的回顾性队列研究,以检查过去四十年来英国黑色素瘤的流行病学是否发生了变化。

方法

1981 - 2018年期间在英国被诊断为黑色素瘤的患者的个体水平数据来自英国国家统计局/英国公共卫生署。在七个五年时间段(1981 - 85年至2011 - 15年)和最近三年时间段(2016 - 18年)内,按三个年龄组(0 - 34岁、35 - 64岁、65岁及以上)、性别和解剖部位计算平均年发病率。发病率的百分比变化计算为从第一个时间段(1981 - 85年)到最后一个时间段(2016 - 18年)平均发病率的变化。使用拟合到按诊断年份划分的发病率的线性趋势线的斜率估计平均年度百分比变化(AAPC)。

结果

在38年期间(1981 - 2018年),英国共登记了265,302例黑色素瘤病例(男性占45.7%,女性占54.3%)。男性的年均病例数从1981 - 85年的每年837例增加到2016 - 18年的每年6963例(增长732%),女性从1981 - 85年的每年1609例增加到2016 - 18年的每年6952例(增长332%)。在年轻年龄组(0 - 34岁),平均年发病率最初从1981 - 85年到2001 - 05年上升,然后在最近时期(2006 - 18年)稳定下来。在中年年龄组(35 - 64岁),男性发病率增加了332%(AAPC为10.4%)(从1981 - 85年的每10万人5.6例增加到2016 - 18年的每10万人24.2例),女性增加了185%(AAPC为5.7%)(从1981 - 85年的每10万人10.2例增加到2016 - 18年的每10万人29.1例);在老年年龄组(65岁及以上),男性发病率增加了842%(AAPC为25.7%)(从1981 - 85年的每10万人9.6例增加到2016 - 18年的每10万人90.4例),女性增加了381%(AAPC为11.2%)(从1981 - 85年的每10万人12.5例增加到2016 - 18年的每10万人60.1例)。男性和女性发病率增加最大的是躯干黑色素瘤(男性增加817%,AAPC为24.8%;女性增加613%,AAPC为18.3%),其次是上肢黑色素瘤(男性增加750%,AAPC为22.9%;女性增加518%,AAPC为15.5%)。

解读

近几十年来,英国年轻人中的黑色素瘤发病率似乎已经稳定(或趋于平稳),而在老年人群中仍在大幅上升。这些发现表明,针对儿童/青少年/家长的公共卫生运动可能对黑色素瘤发病率产生了有利影响。男性发病率上升幅度更大与他们相对更多的阳光暴露和较差的防晒行为一致。所有现有证据表明,自20世纪80年代以来,躯干和上肢黑色素瘤的大幅增加很可能是由于间歇性高强度娱乐性紫外线辐射暴露(如日光浴、在阳光强烈的地方度假、室内晒黑)的增加趋势。

资金

这项工作得到了布莱顿和萨塞克斯医学院(BSMS)的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/7813e998e912/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/289008a9a817/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/f378ecfedc59/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/c8d34203ad9a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/7c0543069ae5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/7813e998e912/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/289008a9a817/gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/f378ecfedc59/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/c8d34203ad9a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/7c0543069ae5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b31c/8454583/7813e998e912/gr5.jpg

相似文献

1
Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in England: An analysis of the national cancer registration data by age, gender and anatomical site, 1981-2018.英国皮肤恶性黑色素瘤的流行病学变化及特定年龄发病率:1981 - 2018年按年龄、性别和解剖部位对国家癌症登记数据的分析
Lancet Reg Health Eur. 2021 Jan 6;2:100024. doi: 10.1016/j.lanepe.2021.100024. eCollection 2021 Mar.
2
Increases in invasive melanoma in England, 1979-2006, by anatomical site.英格兰 1979-2006 年按解剖部位划分的侵袭性黑色素瘤发病率上升。
Br J Dermatol. 2011 Oct;165(4):859-64. doi: 10.1111/j.1365-2133.2011.10434.x. Epub 2011 Aug 4.
3
Mortality trend of cutaneous melanoma in Montenegro from 1990-2018.1990-2018 年黑山皮肤黑色素瘤的死亡率趋势。
Eur Rev Med Pharmacol Sci. 2024 May;28(9):3463-3472. doi: 10.26355/eurrev_202405_36192.
4
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
5
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.《全国癌症状况年度报告》第 1 部分:国家癌症统计。
J Natl Cancer Inst. 2021 Nov 29;113(12):1648-1669. doi: 10.1093/jnci/djab131.
6
Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile.高山地区人群皮肤黑色素瘤:发病趋势及临床病理特征。
Curr Oncol. 2022 Mar 21;29(3):2165-2173. doi: 10.3390/curroncol29030175.
7
Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993.新西兰皮肤恶性黑色素瘤:1969 - 1993年按解剖部位划分的趋势
Int J Epidemiol. 2000 Jun;29(3):416-23.
8
Trends in incidence and mortality of tuberculosis in India over past three decades: a joinpoint and age-period-cohort analysis.过去三十年来印度结核病发病率和死亡率的趋势:联合分析和年龄-时期-队列分析。
BMC Pulm Med. 2021 Nov 16;21(1):375. doi: 10.1186/s12890-021-01740-y.
9
Changing epidemiology and age-specific incidence of cutaneous malignant melanoma in Lithuania: an analysis of national cancer registration data by gender and anatomical site, 1991-2015.立陶宛皮肤恶性黑色素瘤的流行病学变化及特定年龄发病率:1991 - 2015年按性别和解剖部位对国家癌症登记数据的分析
Contemp Oncol (Pozn). 2022;26(4):289-293. doi: 10.5114/wo.2023.124920. Epub 2022 Dec 30.
10
Demographics, Risk Factors, and Incidence of Melanoma in Patients in the New England VA Healthcare system.新英格兰退伍军人事务部医疗保健系统中黑色素瘤患者的人口统计学、风险因素及发病率
Mil Med. 2019 May 1;184(5-6):e408-e416. doi: 10.1093/milmed/usy267.

引用本文的文献

1
The Intricacy of Setting Up a Service to Bridge the Gap in Skin Malignancy Treatment for the Frail Population.为体弱人群建立一项弥合皮肤恶性肿瘤治疗差距的服务的复杂性。
Cureus. 2025 Jun 27;17(6):e86853. doi: 10.7759/cureus.86853. eCollection 2025 Jun.
2
Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma in Older Patients: An Overview of Published Data.免疫检查点抑制剂治疗老年晚期黑色素瘤:已发表数据概述
Cancers (Basel). 2025 May 30;17(11):1835. doi: 10.3390/cancers17111835.
3
Impact of Patient's Age and Physician's Professional Background on the Number Needed to Treat in Malignant Melanoma Detection.

本文引用的文献

1
Age-Specific Incidence of Melanoma in the United States.美国特定年龄段的黑色素瘤发病率。
JAMA Dermatol. 2020 Jan 1;156(1):57-64. doi: 10.1001/jamadermatol.2019.3353.
2
Future reduction of cutaneous malignant melanoma due to improved sun protection habits and decreased common melanocytic nevi density among Swedish children?: A follow-up from 2002 to 2012.未来由于瑞典儿童防晒习惯的改善和常见黑素细胞痣密度的降低,皮肤恶性黑色素瘤的发病率会下降吗?一项 2002 年至 2012 年的随访研究。
Eur J Cancer. 2019 Sep;118:149-155. doi: 10.1016/j.ejca.2019.06.016. Epub 2019 Jul 23.
3
Data Resource Profile: National Cancer Registration Dataset in England.
患者年龄和医生专业背景对恶性黑色素瘤检测中需治疗人数的影响。
Cancers (Basel). 2024 Nov 29;16(23):4014. doi: 10.3390/cancers16234014.
4
A retrospective single-institute study reveals a vertical gradient of the density of cutaneous melanoma from head to toe.一项单机构回顾性研究揭示了皮肤黑色素瘤密度从头部到脚趾的垂直梯度。
Skin Health Dis. 2024 Nov 2;4(6):e463. doi: 10.1002/ski2.463. eCollection 2024 Dec.
5
Trends in Melanoma Mortality in Serbia: A 22-Year Population-Based Study.塞尔维亚黑色素瘤死亡率趋势:一项基于22年人口的研究。
Iran J Public Health. 2024 Apr;53(4):828-836. doi: 10.18502/ijph.v53i4.15559.
6
Ultraviolet (UV) radiation: a double-edged sword in cancer development and therapy.紫外线(UV)辐射:在癌症发展和治疗中的双刃剑。
Mol Biomed. 2024 Oct 17;5(1):49. doi: 10.1186/s43556-024-00209-8.
7
Melanoma Incidence and Mortality Trends Among Patients Aged 59 Years or Younger in Sweden.瑞典 59 岁及以下患者的黑色素瘤发病率和死亡率趋势。
JAMA Dermatol. 2024 Nov 1;160(11):1201-1210. doi: 10.1001/jamadermatol.2024.3514.
8
Skin health of community-living older people: a scoping review.社区居住老年人的皮肤健康:范围综述。
Arch Dermatol Res. 2024 Jun 1;316(6):319. doi: 10.1007/s00403-024-03059-0.
9
A New Approach to Melanoma Treatment: microRNAs.一种新的黑素瘤治疗方法:microRNAs。
Curr Top Med Chem. 2024;24(16):1362-1376. doi: 10.2174/0115680266291290240417081544.
10
Spain's Rising Melanoma Threat: A Comprehensive 30-Year Analysis (1990-2019).西班牙不断上升的黑色素瘤威胁:一项为期30年的综合分析(1990 - 2019年)
Cancers (Basel). 2024 Mar 15;16(6):1167. doi: 10.3390/cancers16061167.
数据资源简介:英格兰国家癌症登记数据集
Int J Epidemiol. 2020 Feb 1;49(1):16-16h. doi: 10.1093/ije/dyz076.
4
Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia.迈向皮肤癌的预防与早期检测:澳大利亚皮肤癌宣传活动的演变
Melanoma Manag. 2014 Aug;1(1):75-84. doi: 10.2217/mmt.14.6. Epub 2014 Sep 5.
5
Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014.澳大利亚昆士兰州 1995-2014 年间黑色素瘤发病率和死亡率的代际转移。
Int J Cancer. 2018 Apr 15;142(8):1528-1535. doi: 10.1002/ijc.31141. Epub 2017 Nov 21.
6
The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031.侵袭性黑色素瘤日益加重的负担:到2031年六个易感人群的发病率和新发病例数预测
J Invest Dermatol. 2016 Jun;136(6):1161-1171. doi: 10.1016/j.jid.2016.01.035. Epub 2016 Feb 20.
7
Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.截至2015年欧洲皮肤黑色素瘤的发病率趋势及预测
J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1170-8. doi: 10.1111/jdv.12236. Epub 2013 Aug 21.
8
Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010-2050.干预措施减少紫外线(UVA 和 UVB)暴露对四个欧洲国家 2010-2050 年皮肤癌发病率的潜在影响。
Br J Dermatol. 2012 Aug;167 Suppl 2:53-62. doi: 10.1111/j.1365-2133.2012.11087.x.
9
Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis.因使用日光浴床而导致的皮肤黑色素瘤:系统评价和荟萃分析。
BMJ. 2012 Jul 24;345:e4757. doi: 10.1136/bmj.e4757.
10
International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?国际恶性黑色素瘤发病率趋势 1953-2008 年——最近几代人面临的风险更高还是更低?
Int J Cancer. 2013 Jan 15;132(2):385-400. doi: 10.1002/ijc.27616. Epub 2012 May 21.